Correlation Between Kiora Pharmaceuticals and Ginkgo Bioworks

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kiora Pharmaceuticals and Ginkgo Bioworks at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiora Pharmaceuticals and Ginkgo Bioworks into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiora Pharmaceuticals and Ginkgo Bioworks Holdings, you can compare the effects of market volatilities on Kiora Pharmaceuticals and Ginkgo Bioworks and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiora Pharmaceuticals with a short position of Ginkgo Bioworks. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiora Pharmaceuticals and Ginkgo Bioworks.

Diversification Opportunities for Kiora Pharmaceuticals and Ginkgo Bioworks

0.22
  Correlation Coefficient

Modest diversification

The 3 months correlation between Kiora and Ginkgo is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Kiora Pharmaceuticals and Ginkgo Bioworks Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ginkgo Bioworks Holdings and Kiora Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiora Pharmaceuticals are associated (or correlated) with Ginkgo Bioworks. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ginkgo Bioworks Holdings has no effect on the direction of Kiora Pharmaceuticals i.e., Kiora Pharmaceuticals and Ginkgo Bioworks go up and down completely randomly.

Pair Corralation between Kiora Pharmaceuticals and Ginkgo Bioworks

Given the investment horizon of 90 days Kiora Pharmaceuticals is expected to generate 1.18 times more return on investment than Ginkgo Bioworks. However, Kiora Pharmaceuticals is 1.18 times more volatile than Ginkgo Bioworks Holdings. It trades about -0.03 of its potential returns per unit of risk. Ginkgo Bioworks Holdings is currently generating about -0.06 per unit of risk. If you would invest  3,402  in Kiora Pharmaceuticals on August 23, 2024 and sell it today you would lose (3,060) from holding Kiora Pharmaceuticals or give up 89.95% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Kiora Pharmaceuticals  vs.  Ginkgo Bioworks Holdings

 Performance 
       Timeline  
Kiora Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kiora Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Ginkgo Bioworks Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ginkgo Bioworks Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Kiora Pharmaceuticals and Ginkgo Bioworks Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kiora Pharmaceuticals and Ginkgo Bioworks

The main advantage of trading using opposite Kiora Pharmaceuticals and Ginkgo Bioworks positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiora Pharmaceuticals position performs unexpectedly, Ginkgo Bioworks can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ginkgo Bioworks will offset losses from the drop in Ginkgo Bioworks' long position.
The idea behind Kiora Pharmaceuticals and Ginkgo Bioworks Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data